04/09/2024 7:46 AM | Acasti Pharma (Subject) HIRSCHMAN ORIN (Filed by)
| Form SC 13G | |
04/01/2024 7:00 AM | Acasti Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/13/2024 6:03 PM | Acasti Pharma (Subject) BANK OF AMERICA CORP /DE/ (Filed by)
| Form SC 13G | |
02/12/2024 7:00 AM | Acasti Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/12/2024 6:30 AM | Acasti Pharma (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
01/08/2024 7:00 AM | Acasti Pharma (Issuer) DelAversano Robert J (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
01/08/2024 6:30 AM | Acasti Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
|
12/15/2023 6:30 AM | Acasti Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/13/2023 7:10 AM | Acasti Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/13/2023 6:30 AM | Acasti Pharma (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
10/23/2023 3:30 PM | Acasti Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/20/2023 11:21 AM | Acasti Pharma (Issuer) DAVIS A BRIAN (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
10/20/2023 11:22 AM | Acasti Pharma (Issuer) NEUGEBOREN EDWARD (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
10/20/2023 11:23 AM | Acasti Pharma (Issuer) Kottayil George (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
10/16/2023 11:15 PM | Acasti Pharma (Filer)
| Form EFFECT | |
10/16/2023 3:31 PM | Acasti Pharma (Filer)
| Form 424B3 | |
10/11/2023 3:30 PM | Acasti Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/10/2023 6:40 AM | Acasti Pharma (Filer)
| Form D Notice of Exempt Offering of Securities | |
10/06/2023 3:30 PM | Acasti Pharma (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
09/27/2023 6:46 PM | Acasti Pharma (Issuer) Kavuru Vimal (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/26/2023 7:10 AM | Acasti Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/25/2023 4:01 PM | Acasti Pharma (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/25/2023 3:15 PM | Acasti Pharma (Filer)
| Form DEF 14A | |
08/25/2023 3:21 PM | Acasti Pharma (Filer)
| Form DEFA14A | |
08/11/2023 6:31 AM | Acasti Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/11/2023 6:15 AM | Acasti Pharma (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
07/24/2023 4:30 PM | Acasti Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/18/2023 3:32 PM | Acasti Pharma (Issuer) D'Andrea Carrie (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/18/2023 3:34 PM | Acasti Pharma (Issuer) Macdonald R. Loch (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/18/2023 3:36 PM | Acasti Pharma (Issuer) Olds Donald (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/18/2023 3:36 PM | Acasti Pharma (Issuer) Kavuru Vimal (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/18/2023 3:37 PM | Acasti Pharma (Issuer) Derby Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/18/2023 3:26 PM | Acasti Pharma (Issuer) Kohli Prashant (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/18/2023 3:28 PM | Acasti Pharma (Issuer) Kumar Amresh (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/07/2023 7:30 AM | Acasti Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/23/2023 6:31 AM | Acasti Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/23/2023 6:01 AM | Acasti Pharma (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
05/26/2023 2:06 PM | Acasti Pharma (Issuer) Macdonald R. Loch (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |